论文部分内容阅读
目的探讨长江流域6城市2006—2008年钙通道阻滞药(CCB)利用情况与发展趋势。方法对长江流域185家医院3年间应用CCB的种类、用药金额及用药频度等进行分析排序。结果 2006—2008年长江流域185家医院CCB的用药金额逐年增长,2008年达43 956.59万元,平均年增长率为18.75%。6市用药金额及用药频度排序中占前列的主要包括氨氯地平、硝苯地平、非洛地平和左旋氨氯地平。结论 CCB类药物用药仍保持快速增长趋势,氨氯地平、硝苯地平、非洛地平和左旋氨氯地平为6市最常使用的CCB品种。
Objective To explore the utilization status and development trend of calcium channel blockers (CCBs) in 6 cities in the Yangtze River valley from 2006 to 2008. Methods The types of CCB, the amount of medication and frequency of medication in 185 hospitals in the Yangtze River basin were analyzed and sorted in three years. Results The amount of CCB in 185 hospitals in the Yangtze River valley increased from 2006 to 2008, reaching RMB435.5659 million in 2008 with an average annual growth rate of 18.75%. 6 city drug amount and frequency of medication in the forefront of the list include amlodipine, nifedipine, felodipine and levamlodipine. CONCLUSIONS: The use of CCB drugs has maintained a rapid growth trend. Amlodipine, nifedipine, felodipine and levamlodipine are the most commonly used CCB varieties in 6 cities.